Pomdoctor Statistics
Total Valuation
Pomdoctor has a market cap or net worth of $645.51 million. The enterprise value is $708.36 million.
Important Dates
The last earnings date was Wednesday, December 3, 2025, after market close.
| Earnings Date | Dec 3, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Pomdoctor has 118.44 million shares outstanding. The number of shares has increased by 56.11% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 118.44M |
| Shares Change (YoY) | +56.11% |
| Shares Change (QoQ) | +112.23% |
| Owned by Insiders (%) | 21.83% |
| Owned by Institutions (%) | n/a |
| Float | 46.49M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 4.03 |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 13.83 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.17
| Current Ratio | 0.17 |
| Quick Ratio | 0.13 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -1.97 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -32.56% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 16.81% |
| Revenue Per Employee | $328,274 |
| Profits Per Employee | -$133,239 |
| Employee Count | 156 |
| Asset Turnover | 7.33 |
| Inventory Turnover | 31.33 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 61.54 |
| Average Volume (20 Days) | 2,407,850 |
Short Selling Information
The latest short interest is 102,202, so 0.09% of the outstanding shares have been sold short.
| Short Interest | 102,202 |
| Short Previous Month | 34,969 |
| Short % of Shares Out | 0.09% |
| Short % of Float | 0.22% |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Pomdoctor had revenue of $51.21 million and -$20.79 million in losses. Loss per share was -$0.55.
| Revenue | 51.21M |
| Gross Profit | 7.21M |
| Operating Income | -3.64M |
| Pretax Income | -20.79M |
| Net Income | -20.79M |
| EBITDA | -3.62M |
| EBIT | -3.64M |
| Loss Per Share | -$0.55 |
Full Income StatementBalance Sheet
The company has $802,226 in cash and $63.66 million in debt, giving a net cash position of -$62.85 million or -$0.53 per share.
| Cash & Cash Equivalents | 802,226 |
| Total Debt | 63.66M |
| Net Cash | -62.85M |
| Net Cash Per Share | -$0.53 |
| Equity (Book Value) | -72.53M |
| Book Value Per Share | -8.61 |
| Working Capital | -22.96M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$2.86 million and capital expenditures -$3,086, giving a free cash flow of -$2.90 million.
| Operating Cash Flow | -2.86M |
| Capital Expenditures | -3,086 |
| Free Cash Flow | -2.90M |
| FCF Per Share | -$0.02 |
Full Cash Flow StatementMargins
Gross margin is 14.08%, with operating and profit margins of -7.11% and -40.59%.
| Gross Margin | 14.08% |
| Operating Margin | -7.11% |
| Pretax Margin | -40.59% |
| Profit Margin | -40.59% |
| EBITDA Margin | -7.07% |
| EBIT Margin | -7.11% |
| FCF Margin | n/a |